Comparison of Dopamine and Norepinephrine in the Treatment of Shock
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0.19 microg per kilogram per minute for norepinephrine, open-label norepinephrine, epinephrine, or vasopressin could be added. The primary outcome was the rate of death at 28 days after randomization; secondary end points included the number of days without need for organ support and the occurrence of adverse events. RESULTS: The trial included 1679 patients, of whom 858 were assigned to dopamine and 821 to norepinephrine. The baseline characteristics of the groups were similar. There was no significant between-group difference in the rate of death at 28 days (52.5% in the dopamine group and 48.5% in the norepinephrine group; odds ratio with dopamine, 1.17; 95% confidence interval, 0.97 to 1.42; P=0.10). However, there were more arrhythmic events among the patients treated with dopamine than among those treated with norepinephrine (207 events [24.1%] vs. 102 events [12.4%], P<0.001). A subgroup analysis showed that dopamine, as compared with norepinephrine, was associated with an increased rate of death at 28 days among the 280 patients with cardiogenic shock but not among the 1044 patients with septic shock or the 263 with hypovolemic shock (P=0.03 for cardiogenic shock, P=0.19 for septic shock, and P=0.84 for hypovolemic shock, in Kaplan-Meier analyses). CONCLUSIONS: Although there was no significant difference in the rate of death between patients with shock who were treated with dopamine as the first-line vasopressor agent and those who were treated with norepinephrine, the use of dopamine was associated with a greater number of adverse events. (ClinicalTrials.gov number, NCT00314704.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dopamine (DA) is a neurotransmitter in the catechol family, which is often used as first-line vasoactive drug in patients with septic shock (43).”
From Dopamine Is a Siderophore-Like Iron Chelator That Promotes Salmonella enterica Serovar Typhimurium Virulence in Mice (2019) · cites this paper as [43]
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Self-citationWriting Committee Members, Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E. R., Green, L. A., Hand, M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,356
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Self-citationCDC definitions for nosocomial infections, 1988
Garner, J. S., Jarvis, W. R., Emori, T. G., Horan, T. C., & Hughes, J. M. (1988) · American Journal of Infection Control · doi:10.1016/0196-6553(88)90053-3 · Cited by 5,672
CDC definitions for nosocomial infections
Yangco, B. G. (1989) · American Journal of Infection Control · doi:10.1016/s0196-6553(89)80013-6 · Cited by 3,770
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Treating Patients with Severe Sepsis
Wheeler, A. P., & Bernard, G. R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400307 · Cited by 992
Current Epidemiology of Septic Shock: The CUB-Réa Network
Annane, D., Aegerter, P., Jars-Guincestre, M. C., & Guidet, B. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2201087 · Cited by 637
Research works printed but not linked: 1
- Mullner M, 2004, Cochrane Database Syst Rev, 3, CD003709
Cited by
Items 901–1,000 of 1,000
Pétursson, P., Guðmundsson, Þ. H., Råmunddal, T., Angerås, O., Rawshani, A., Mohammad, M. A., Persson, J., Alfredsson, J., Hofmann, R., Jernberg, T., et al. (2024) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvae078 · Cited by 9
“…about the safety and efficacy of inotropes, suggesting that they may be associated with an increased mortality risk in patients with CS. 7 , 20 –22 Our study highlights the risks associated with inotropic therapy and underscores the need for careful consideration when determining appropriate…”
Menezes, A. D. S., Nogueira, T. H. M., de Lima, K. B. A., de Oliveira, H. L., & Botelho, S. M. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm15010003 · Cited by 9
McDonald, R., Burns, M., Wong, A., Smith, C., Ostermann, M., & Hutchings, S. (2025) · Critical Care · doi:10.1186/s13054-025-05573-7 · Cited by 9
“The study by Zampieri et al. is an exploratory post-hoc analysis of the SOAP II study [54, 55].”
Pei, X., Ma, P., Li, J., Du, Z., Zhou, Q., Lu, Z., Luo, Y., & Hu, B. (2015) · Chinese Medical Journal · doi:10.4103/0366-6999.155064 · Cited by 9
“In fact, norepinephrine has increasingly proven to be of benefit in the management of hypovolemic and cardiogenic shock by either venous α or β2‐adrenergic stimulation [18‐20] and decreases myocardial oxygen consumption in situations of tachycardia and tachyarrhythmias.[21,22] It is also recommended as the first choic…”
BackgroundMalignant Arrhythmias During Induction of Target Temperature Management After Cardiac Arrest
Adler, C., Schregel, F., Heller, T., Hellmich, M., Adler, J., & Reuter, H. (2019) · Therapeutic Hypothermia and Temperature Management · doi:10.1089/ther.2019.0025 · Cited by 9
Reynolds, P., Wells, L., MacLaren, R., & Scoular, S. K. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2371 · Cited by 9
Comparison of Vasopressor Duration in Septic Shock Patients With and Without Cirrhosis
Durst, M. M., Eitzen, E. A., & Benken, S. T. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020980727 · Cited by 9
Barlow, B., & Bissell, B. D. (2021) · Shock · doi:10.1097/shk.0000000000001783 · Cited by 9
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva · doi:10.1016/j.medin.2022.02.003 · Cited by 9
First-Line Vasopressor Use in Septic Shock and Route of Administration: An Epidemiologic Study
Teja, B. J., Bosch, N. A., Wijeysundera, D. N., Wijeysundera, H. C., Saskin, R., Hill, A. D., Stelfox, H. T., Walkey, A. J., & Wunsch, H. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202203-222oc · Cited by 9
Udesen, N. L. J., Helgestad, O. K. L., Josiassen, J., Hassager, C., Højgaard, H. F., Linde, L., Kjærgaard, J., Holmvang, L., Jensen, L. O., Schmidt, H., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272279 · Cited by 9
Zhang, X., Ni, J., Zhang, H., & Diao, M. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1204099 · Cited by 9
“It can also interact with V1a receptors to contract vascular smooth muscle cells, thus increasing blood pressure (53).”
BackgroundThe Ins and Outs of IV Fluids in Hemodynamic Resuscitation
Kaufman, D. A., Lopes, M. A., Malviya, N., & Magder, S. A. (2023) · Critical Care Medicine · doi:10.1097/ccm.0000000000006001 · Cited by 9
“The amount of leakage is lower during hypovolemia; if albumin is the colloid, leaked albumin can return to the plasma via lymphatics, if it is not broken down in the interstitium (27, 49).”
BackgroundSepsis Management in the Cardiac Intensive Care Unit
Zhang, Y., McCurdy, M. T., & Ludmir, J. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10100429 · Cited by 9
“Historically, dopamine has been widely used for shock due to its interesting dose-dependent dopaminergic and adrenergic receptor agonism; however, comparison studies against norepinephrine have shown more frequent adverse events such as dysrhythmias and increased mortality in patients with CS [72].”
Background[b]Physiopathologie[/b] et traitement de la vasoplégie au cours du sepsis
Jeanneret, S., Sanchez, B., & Liaudet, L. (2011) · JMIG · doi:10.53738/revmed.2011.7.321.2435 · Cited by 9
Secuencia rápida de intubación en cuidados intensivos
Jaramillo, R. P., Castell, C. R. D., & Ortíz, G. (2012) · Colombian Journal of Anesthesiology · doi:10.1016/j.rca.2012.07.005 · Cited by 9
Current management of Gram-negative septic shock
Vincent, J., & Mongkolpun, W. (2018) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000492 · Cited by 9
Self-citationFifty Years of Management of Vasodilatory Shock
Arias, J., Lévy, B., & Backer, D. D. (2019) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000226 · Cited by 9
Oyama, Y., Blaskowsky, J., & Eckle, T. D. L. G. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190618124829 · Cited by 9
Extracorporeal Membrane Oxygenation in Infarct-Related Cardiogenic Shock
Freund, A., Desch, S., Pöss, J., Sulimov, D. S., Sandri, M., Majunke, N., & Thiele, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11051256 · Cited by 9
“A subgroup analysis of the SOAP-II trial showed worse outcomes of dopamine treatment compared to norepinephrine in AMI-CS [38].”
MethodEvaluation and treatment of the critically ill cirrhotic patient
Fernández, J., Aracil, C., Solà, E., Soriano, G., Cardona, M. C., Coll, S., Genescà, J., Hombrados, M., Morillas, R. M., Martín–Llahí, M., et al. (2016) · Gastroenterología y Hepatología (English Edition) · doi:10.1016/j.gastre.2016.10.004 · Cited by 9
Iovine, J. A., Villanueva, R. D., Werth, C., Hlavacek, N. L., Rollstin, A. D., Tawil, I., & Sarangarm, P. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac164 · Cited by 9
Perioperative Maintenance of Tissue Perfusion and Cardiac Output in Cardiac Surgery Patients
Lighthall, G. K., & Singh, S. P. (2014) · Seminars in Cardiothoracic and Vascular Anesthesia · doi:10.1177/1089253214534781 · Cited by 9
Einav, S., Bromiker, R., & Sela, H. Y. (2017) · Current anesthesiology reports · doi:10.1007/s40140-017-0198-5 · Cited by 9
Inferior vena cava obstruction and shock
MEGRI, M. A., Elhamdani, S., Abusnina, W. A., Majdi, A., & Shweihat, Y. (2018) · Journal of Emergencies Trauma and Shock · doi:10.4103/jets.jets_22_17 · Cited by 9
“The most frequent shock presenting to the Intensive Care Unit is septic shock,[1,2] which has the highest mortality rate compared to other forms of shock.”
BackgroundClinical practice guidelines for the provision of renal service in Hong Kong: General Nephrology
Tang, S. C. W., Wong, A. K., & Mak, S. (2019) · Nephrology · doi:10.1111/nep.13500 · Cited by 9
Nandkeolyar, S., Ryu, R. J., Mohammad, A., Cordero‐Cabán, K., Abramov, D., Tran, H. N., Hauschild, C., Stoletniy, L. N., Hilliard, A. A., & Sakr, A. E. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001078 · Cited by 9
Kunadian, V., Coats, L., Kini, A. S., & Mehran, R. (2012) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2012.01.006 · Cited by 9
Norepinephrine: more of a neurohormone than a vasopressor
Myburgh, J. (2010) · Critical Care · doi:10.1186/cc9246 · Cited by 9
“Th ree recently published randomised controlled trials comparing the eff ects of catecholamines in severe sepsis have demonstrated equivalence in haemodynamic responses without adverse eff ects on organ function or mortality [ 8-10 ].”
BackgroundPhysicians declining patient enrollment in clinical trials: what are the implications?
Backer, D. D., & Schortgen, F. (2013) · Intensive Care Medicine · doi:10.1007/s00134-013-3151-1 · Cited by 9
“refusals are often not reported [1–5].”
Pulmonary Circulation in Advanced Heart Failure and Cardiogenic Shock: State-of-the-Art Review
Hungerford, S. L., Everett, K. D., Lau, E., Burkhoff, D., & Kapur, N. K. (2025) · Circulation Heart Failure · doi:10.1161/circheartfailure.124.012611 · Cited by 8
Iwasaki, Y., Kinoshita, T., Yoshimura, J., Maruyama, S., Ohshimo, S., Murao, S., Watanabe, M., Uchida, K., Igarashi, Y., Nishimoto, Y., et al. (2026) · Critical Care · doi:10.1186/s13054-026-06020-x · Cited by 8
“…including the respiratory domain with updated oxygenation thresholds and contemporary support strategies [23], the cardiovascular domain with norepinephrine-equivalent vasopressor dosing and MCS or V-A ECMO use [24–27], and the renal domain incorporating RRT according to KDIGO definitions [28].”
Risk Factors for Intraoperative Pressure Injury in Aortic Surgery: A Nested Case-Control Study
Dong, Y., Liu, J., & Song, L. (2020) · Cardiovascular Innovations and Applications · doi:10.15212/cvia.2019.1263 · Cited by 8
Updates in the Management of Perioperative Vasoplegic Syndrome
Brennan, K. M., Bhutiani, M., Kingeter, M. A., & McEvoy, M. D. (2022) · Advances in Anesthesia · doi:10.1016/j.aan.2022.07.010 · Cited by 8
Selby, A. R., Khan, N. S., Dadashian, T., & Hall, R. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041344 · Cited by 8
“Landmark trials documenting the need to utilize norepinephrine as a first-line vasoactive agent in septic shock utilized different dosing strategies [2,13].”
BackgroundResultTorre, A., Cisneros-Garza, L. E., Castillo-Barradas, M., Navarro–Álvarez, N., Sandoval-Salas, R., González-Huezo, M. S., Pérez-Hernández, J. L., Méndez-Guerrero, O., Ruiz-Manríquez, J. A., Trejo-Estrada, R., et al. (2023) · Annals of Hepatology · doi:10.1016/j.aohep.2023.101140 · Cited by 8
Dose-related effects of norepinephrine on early-stage endotoxemic shock in a swine model
Xiang, H., Zhao, Y., Ma, S., Li, Q., KASHANI, K. B., Peng, Z., Li, J., & Hu, B. (2023) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2023.06.007 · Cited by 8
Benefits and Risks of Medications Used in the Management of Hypotension: A Review
Skylynn, T., Abel, T., Christopher, L., Suliman, G., Dominic, R. M. S., Joel, V., Yu, Z., & Pemminati, S. (2024) · Cureus · doi:10.7759/cureus.51608 · Cited by 8
Bloom, J. E., Nehme, E., Paratz, E. D., Dawson, L. P., Nelson, A. J., Ball, J., Eliakundu, A. L., Voskoboinik, A., Anderson, D. J., Bernard, S., et al. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-078435 · Cited by 8
Limb Necrosis in the Setting of Vasopressor Use
Derry, K. H., Rocks, M. C., Izard, P., Nicholas, R. S., Sommer, P. M., & Hacquebord, J. H. (2024) · American Journal of Critical Care · doi:10.4037/ajcc2024171 · Cited by 9
Taha, H., Gohar, A., Ammar, W., Alhossary, H., Adel, A., Diab, R., Mahfouz, H., Shaker, M. M., & Samy, M. (2024) · The Egyptian Heart Journal · doi:10.1186/s43044-024-00525-y · Cited by 8
“However, in the subgroup of CS patients, dopamine was associated with a greater number of adverse events, but there was no significant difference in mortality [32].”
BackgroundHyun, J., Pack, D., Bak, M., Park, H., Kim, H. Y., Lee, S., Kim, I., Kim, S. R., Kim, M., Kim, K., et al. (2024) · Korean Circulation Journal · doi:10.4070/kcj.2024.0229 · Cited by 8
“Although norepinephrine is regarded as preferable to dopamine, 22) issues regarding first-line agents and optimal combinations of agents for medical therapy of FM have not yet been resolved.”
Wstrząs kardiogenny – możliwości diagnostyczne i terapeutyczne w świetle nowych doniesień naukowych
Szymański, F. M., & Filipiak, K. J. (2014) · Anestezjologia, Intensywna Terapia · doi:10.5603/ait.2014.0049 · Cited by 8
Evidence-based Management of Cardiogenic Shock After Acute Myocardial Infarction
Werdan, K., Ruß, M., Buerke, M., Prondzinsky, R., Dietz, S., Dachau, Siegen, Merseburg, G., & Halle(Saale) (2013) · Interventional Cardiology Reviews Research Resources · doi:10.15420/icr.2013.8.2.73 · Cited by 8
Cardiogenic shock management: Still a challenge and a need for large-registry data
Delmas, C., Leurent, G., Lamblin, N., Bonnefoy‐Cudraz, E., & Roubille, F. (2017) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2017.03.002 · Cited by 8
Smith, S. E., Peters, N. A., Floris, L. M., Patterson, J. M., & Hawkins, W. A. (2022) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxac069 · Cited by 8
Hyun, J., Cho, J. Y., Youn, J., Kim, D., Cho, D., Park, S. M., Jung, M., Cho, H., Park, S., Choi, J., et al. (2023) · Korean Circulation Journal · doi:10.4070/kcj.2023.0115 · Cited by 8
Clinical Year in Review 2014: Critical Care Medicine
Lee, J. M., & Lee, H. B. (2014) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2014.77.1.6 · Cited by 8
Septic shock: The initial moments and beyond
Lam, S. W., Bauer, S. R., & Guzmán, J. A. (2013) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.80a.12002 · Cited by 8
Zhao, D. X.-M., Radford, J., Tamis‐Holland, J. E., Tommaso, C. L., Tracy, C. M., Linderbaum, J. A., Morrow, D. A., Newby, L. K., Ornato, J. P., Fesmire, F. M., et al. (2014) · Cited by 8
Incidence of intraoperative hypotension in acute traumatic spinal cord injury and associated factors
Gaudin, X., Wochna, J. C., Wolff, T. W., Pugh, S. M., Pandya, U. B., Spalding, M. C., & Narayan, K. K. (2019) · Journal of Neurosurgery Spine · doi:10.3171/2019.7.spine19132 · Cited by 8
Pharmacological therapy of acute heart failure: what is available now and what is expected in future
Еременко, А. А. (2020) · Messenger of Anesthesiology and Resuscitation · doi:10.21292/2078-5658-2020-17-2-29-37 · Cited by 8
Carsetti, A., Bignami, E., Cortegiani, A., Donadello, K., Donati, A., Foti, G., Grasselli, G., ROMAGNOLI, S., Antonelli, M. M., Blasio, E. D., et al. (2021) · Minerva Anestesiologica · doi:10.23736/s0375-9393.20.14866-1 · Cited by 8
Kovács, E., Gyarmathy, V. A., Pilecky, D., Fekete-Győr, A., Szakál‐Tóth, Z., Gellér, L., Hauser, B., Gál, J., Merkely, B. P., & Zima, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18105223 · Cited by 8
“It is well known that long-term catecholamine administration itself may worsen the outcome [38,39].”
BackgroundDezillio, L. E. V., Romanin, D., Marinoff, I. I., Vernengo, J., Abate, J. C., Machuca, M., Gondolesi, G. E., Lausada, N., Stringa, P. L., & Rumbo, M. (2021) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000003473 · Cited by 8
Elzanaty, A., Maraey, A. M., Khalil, M., Elsharnoby, H. R., Nazir, S., & Moukarbel, G. V. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101388 · Cited by 8
Buchtele, N., Schwameis, M., Roth, D., Schwameis, F., Kraft, F., Ullrich, R., Mühlbacher, J., Laggner, R., Gamper, G., Semmler, G., et al. (2022) · Clinical Epidemiology · doi:10.2147/clep.s372340 · Cited by 8
Belletti, A., Azzolini, M. L., Baldetti, L., Landoni, G., Franco, A., & Zangrillo, A. (2022) · General Reanimatology · doi:10.15360/1813-9779-2022-5-60-77 · Cited by 8
Cirrhosis Management in the Intensive Care Unit
Smith, T. N., de Moraes, A. G., & Simonetto, D. A. (2023) · Seminars in Liver Disease · doi:10.1055/a-2015-1290 · Cited by 8
Severe sepsis and septic shock
Toft, P., & Tønnesen, E. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781316401972.030 · Cited by 8
Review of Vasopressor Therapy in the Setting of Vasodilatory Shock
Bockenstedt, T. L., Baker, S. N., Weant, K. A., & Mason, M. A. (2012) · Advanced Emergency Nursing Journal · doi:10.1097/tme.0b013e31824371d3 · Cited by 8
“No difference was found in 28-day mortality (p = 0.10), but dopamine was associated with more adverse events including tachyarrhythmias (p < 0.001; De Backer et al., 2010).”
BackgroundMethodInfluentialKrzysztofik, J., & Ponikowski, P. P. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1299574 · Cited by 8
“Use of norepinephrinemay be associated with lowermortality and fewer side effects than dopamine [1,27,68].”
BackgroundThe crashing patient: hemodynamic collapse
Gidwani, H., & Gómez, H. (2017) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000451 · Cited by 8
“neurogenic or anaphylactic, 4%) and obstructive shock (2%) [4].”
Nonogi, H. (2018) · Journal of Cardiology · doi:10.1016/j.jjcc.2018.10.001 · Cited by 8
Blood pressure measurement in patients with cardiogenic shock: the effect of norepinephrine
Hromádka, M., Tůmová, P., Rokyta, R., & Seidlerová, J. (2019) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000393 · Cited by 8
Lessons learned from kidney dysfunction: Preventing organ failure
John, S. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00659-2 · Cited by 8
Bahloul, M., Tounsi, A., Algia, N. B., Chaari, A., Chtara, K., Dammak, H., Rekik, N., Hamida, C. B., Chelly, H., & Bouaziz, M. (2013) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318251f0eb · Cited by 8
Brusatori, S., Krbec, M., Zadek, F., Zanella, A., Grasselli, G., Duska, F., & Langer, T. (2022) · Intensive Care Medicine Experimental · doi:10.1186/s40635-022-00469-0 · Cited by 8
Anisodamine microcirulatory effects in septic shock: be aware of cardiac side effects
Honoré, P. M., Redant, S., Préseau, T., Cismas, B. V., Kaefer, K. M., Gutierrez, L. B., Anane, S., Attou, R., Gallerani, A., & Bels, D. D. (2021) · Critical Care · doi:10.1186/s13054-021-03854-5 · Cited by 8
“627) during the treatment, which is lower than in the previous study [7].”
ResultPirracchio, R., Pařenica, J., Resche‐Rigon, M., Chevret, S., Špinar, J., Jarkovský, J., Zannad, F. M., Alla, F., Mebazaa, A., & for the GREAT network (2013) · PLoS ONE · doi:10.1371/annotation/add6bc4f-dec0-4c95-a609-67563469b831 · Cited by 8
Alviar, C. L., Hall, S. F., & Mebazaa, A. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.01.007 · Cited by 8
Impact of Norepinephrine Use on Free Flap Survival in Breast Reconstructive Microsurgery
Larcher, Q., Mernier, T., Feigna, M., Pozzo, V., & Lantieri, L. A. (2025) · Microsurgery · doi:10.1002/micr.70026 · Cited by 7
Mortality time frame variability in septic shock clinical trials: A systematic review
Laserna, A., Cuenca, J. A., Martin, P., Fowler, C., Correa, J. E. B., Manjappachar, N. K., Fowler, C. S., Lopez-Olivo, M. A., Borges, M., Sprung, C. L., et al. (2025) · Medicina Intensiva · doi:10.1016/j.medine.2025.502172 · Cited by 7
The Immediate Cardiovascular and Mitochondrial Response in Ischemic Cardiogenic Shock
Hørsdal, O. K., Frederiksen, P. H., Helgestad, O. K. L., Ravn, H. B., Møller, J. E., Wiggers, H., Nielsen, R. R., Gopalasingam, N., & Hansen, K. B. (2025) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-025-10647-6 · Cited by 7
“However, excessive stressors, such as combined inopressors, can further strain the myocardium [47, 48].”
Greenwood, J. C., Ratnayake, C., Shabbir, M., Opitz, S. E., Jang, D. H., Choi, W., Panebianco, N. L., Shofer, F. S., Augoustides, J. G., Bakker, J., et al. (2025) · Intensive Care Medicine Experimental · doi:10.1186/s40635-025-00806-z · Cited by 7
“Recent trials have compared the effect of different inotropes on patient outcomes, but the effect of time between shock onset and inotropic therapy has not been explored [10, 11].”
Hosoya, Y., Yamamoto, M., Hanada, H., Osawa, T., Arai, M., Sakamoto, K., Okazaki, Y., Katasako-Yabumoto, A., Ishizu, T., Kondo, T., et al. (2025) · Circulation Reports · doi:10.1253/circrep.cr-25-0188 · Cited by 7
“26 The study by De Backer et al. (2010) was a”
InfluentialJohnston, D. T., & Grau, J. W. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1716013 · Cited by 7
Practical Guide to Clazosentan Administration in Patients with Aneurysmal Subarachnoid Hemorrhage
SUZUKI, H., Akamatsu, Y., Hiroshi, A. B. E., Iihoshi, S., Ikawa, F., Izumo, T., Endo, H., Kataoka, H., KAWAMOTO, S., Kikuta, K., et al. (2026) · Neurologia medico-chirurgica · doi:10.2176/jns-nmc.2025-0439 · Cited by 7
“43) In a clinical trial comparing dopamine and norepinephrine as vasopressors during shock, 44) the dopamine group showed a higher incidence of arrhythmias; therefore, guidelines recommend norepinephrine as the first choice.”
Champion, S., & Deye, N. (2016) · Annales de Cardiologie et d Angéiologie · doi:10.1016/j.ancard.2016.10.013 · Cited by 7
Colorectal Surgery in Critically Unwell Patients: A Multidisciplinary Approach
Subramaniam, A., Wengritzky, R., Skinner, S. A., & Shekar, K. (2022) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0041-1740045 · Cited by 7
Yu, Y. S., Rao, J., Xu, Q., Xiao, J. Z., Cheng, P., Wang, J., Wang, X., Wang, P., Zhang, Y., & Wang, Z. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1186119 · Cited by 7
Ceausu, D., Boulet, N., Roger, C., Alonso, S., Lefrant, J., Boisson, C., Mura, T., & Muller, L. (2024) · Shock · doi:10.1097/shk.0000000000002454 · Cited by 7
“As a secondary endpoint, the time to reach the maximal NE infusion rate was shorter in survivors than in nonsurvivors (4.0 [0 – 16] vs. 8.0 [ 2 –”
InfluentialApplication of norepinephrine in the treatment of septic shock: a meta-analysis
Xu, Q., Jin, Y., Fu, L., & Li, Y. (2024) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-024-03827-x · Cited by 7
Management of non-Cardiac Organ Failure in cardiogenic shock
Mehta, C., Shin, A., Osorio, B., DePolo, D., Vargas, I., Hao, E., Khan, A. A., Chandragiri, S., Shringi, S., Diaz, P. O. M., et al. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100549 · Cited by 7
“Unfortunately, no vasoactive drug has demonstrated superior outcomes in CRS. Low-dose dopamine has theoretical benefit by dilating the renal afferent arteriole but is associated with worse outcomes in CS when compared to norepinephrine [101].”
Peschanski, N., Ray, P., Depil-Duval, A., Renard, A., Avondo, A., & Chouihed, T. (2018) · Médecine Intensive Réanimation · doi:10.3166/rea-2018-0036 · Cited by 7
Nonischemic Causes of Cardiogenic Shock
Wilcox, S. R. (2019) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2019.03.007 · Cited by 7
Haiduc, M., Radparvar, S., Aitken, S. L., & Altshuler, J. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066619896292 · Cited by 7
“% time HR >110 (24 hours) 42 (25-67) 33 (13-71) .”
Ghasemiyeh, P., Mohammadi‐Samani, S., Firouzabadi, N., Vazin, A., & Zand, F. (2021) · Trends in Anaesthesia and Critical Care · doi:10.1016/j.tacc.2021.05.004 · Cited by 7
A Machine Learning Pipeline for Mortality Prediction in the ICU
Sun, Y., & Zhou, Y. (2022) · International Journal of Digital Health · doi:10.29337/ijdh.44 · Cited by 7
All intraoperative hypotension is not created equal – A call for an individualized approach
Khanna, A. K., Zarbock, A., & Legrand, M. M. (2023) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2023.111076 · Cited by 7
Lemos, A. L. M. A., Camillo, B. D. Q., Alves, E. C. M., Carrijo, L. F., Cavalcante, L. D. A. L., Vieira, M. V. A., Levy, M. S. D. F. E. S., & Fernandes, M. A. (2024) · EPITAYA eBooks · doi:10.47879/ed.ep.2024264p429x · Cited by 7
Carlos Romero, P., & Glenn Hernández, P. (2013) · Revista médica de Chile · doi:10.4067/s0034-98872013000900010 · Cited by 7
Amsterdam, E. A., WENGER, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H. M., Kelly, R. F., Kontos, M. C., et al. (2014) · Cited by 7
Shock treatment in a cohort of Scandinavian intensive care units in 2014
Kollind, M., Wickbom, F., Wilkman, E., Snäckestrand, M. S. C., Holmén, A., Oldner, A., Perner, A., Åneman, A., Chew, M. S., & for the Scandinavian Critical Care Trials Group (2016) · Acta Anaesthesiologica Scandinavica · doi:10.1111/aas.12745 · Cited by 7
“Liver disease 7 (4) 2–8 3 (6) 1–15 1 (3) 0–15”
InfluentialSepsis-Induced Myocardial Dysfunction and Mammalian Target of Rapamycin Signalling Pathways
Walley, K. R. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.04.003 · Cited by 7
Vasoplegia in patients following ventricular assist device explant and heart transplantation
Emmanuel, S., Pearman, M., Jansz, P. C., & Hayward, C. (2021) · Perfusion · doi:10.1177/0267659121989229 · Cited by 7
Yagi, T., Nagao, K., Tachibana, E., Yonemoto, N., Sakamoto, K., Ueki, Y., Imamura, H., Miyamoto, T., Takahashi, H., Hanada, H., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.648824 · Cited by 7
“In addition, the same study reported that the dopamine treatment was more closely associated with increased 28-day mortality rate than the norepinephrine treatment for patients in cardiogenic shock whereas a similar association was not found for patients in septic or hypovolemic shock (6).”
BackgroundMethodResultPerioperative management of patients with renal failure
Zabolotskikh, I. B., Лебединский, К. М., Афончиков, В. С., BAYALIEVA, A. Z., Громова, Е. Г., Левит, А. Л., Lubnin, А. Y., Potievskaya, V. I., Sinkov, S. V., Horoshilov, S. E., et al. (2021) · Russian Journal of Anesthesiology and Reanimatology · doi:10.17116/anaesthesiology20210516 · Cited by 7
Sinha, R., & Nadel, S. (2013) · Paediatrics and Child Health · doi:10.1016/j.paed.2012.11.002 · Cited by 7
Beltran, L. P., Benken, J. J., Jou, J., Benedetti, E., Nishioka, H., Alamreia, E., Belcher, R. M., & Benken, S. T. (2024) · Clinical Transplantation · doi:10.1111/ctr.15432 · Cited by 7
Metadata
- Authors
- De Backer, D., Biston, P., Devriendt, J., Madl, C., Chochrad, D., Aldecoa, C., Brasseur, A., Defrance, P., Gottignies, P., & Vincent, J.-L.
- Affiliations
- Université Libre de Bruxelles (BE)
- Medical University of Vienna (AT)
- Centre hospitalier Etterbeek-Ixelles (BE)
- Erasmus Hospital (BE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-04
- Volume
- 362
- Issue
- 9
- Pages
- 779-789
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2095944485
- Cited by
- 1,940
- References
- 31
- Citations by year
- 2026: 98 · 2025: 107 · 2024: 140 · 2023: 115 · 2022: 125 · 2021: 132 · 2020: 135 · 2019: 138 · 2018: 106 · 2017: 139 · 2016: 99 · 2015: 122 · 2014: 120 · 2013: 96 · 2012: 110
- FWCI
- 83.32
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Trauma, Hemostasis, Coagulopathy, Resuscitation
- Keywords
- dopamine, norepinephrine, vasopressors, shock, cardiogenic shock, septic shock, hypovolemic shock, 28-day mortality, cardiac arrhythmias, epinephrine, vasopressin, organ support, adverse events, subgroup analysis, vasopressor weaning
- MeSH terms
- Aged, Arrhythmias, Cardiac, Combined Modality Therapy, Dopamine, Female, Fluid Therapy, Humans, Male, Middle Aged, Norepinephrine, Shock, Vasoconstrictor Agents, Kaplan-Meier Estimate, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.